Abstract
Transcatheter mitral valve replacement (TMVR) systems with bioprosthetic transcatheter heart valves (THV) originally designed for implantation in the aortic position, have gained widespread acceptance in recent years despite absence of discrete society recommendations. Numerous dedicated TMVR systems are also under investigation currently. Cardiac anesthesiologists working alongside interventional cardiologists will be expected to provide intraprocedural care and potentially echocardiographic guidance for current and future TMVR systems. Device specific echocardiographic training, as well as knowledge of individual devices and procedural steps remain essential for optimal care.
